See more : Silex Systems Limited (SILXF) Income Statement Analysis – Financial Results
Complete financial analysis of Medi-Caps Limited (MEDICAPQ.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Medi-Caps Limited, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
You may be interested
- Omai Gold Mines Corp. (OMG.V) Income Statement Analysis – Financial Results
- Printnet Inc. (7805.T) Income Statement Analysis – Financial Results
- AS Tallink Grupp (TALLINK.HE) Income Statement Analysis – Financial Results
- Philex Mining Corporation (PXMFF) Income Statement Analysis – Financial Results
- Henkel AG & Co. KGaA (HELKF) Income Statement Analysis – Financial Results
Medi-Caps Limited (MEDICAPQ.BO)
About Medi-Caps Limited
Medi-Caps Ltd. manufactures and markets pharmaceuticals products. Its products include Empty Hard Gelatin Capsules, Halal Gelatin Capsules, and Liquid Filled Capsules. The company was founded by Ramesh Chandra Mittal on August 6, 1983 and is headquartered in Indore, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 265.64M | 485.78M | 683.11M | 574.16M | 430.52M | 517.83M | 496.75M | 440.38M | 429.71M | 361.11M | 374.89M | 300.17M | 259.76M | 260.82M | 205.31M | 206.24M | 180.66M |
| Cost of Revenue | 188.20M | 251.09M | 334.54M | 320.76M | 273.38M | 315.27M | 323.77M | 275.01M | 263.03M | 232.17M | 166.80M | 99.25M | 80.12M | 85.93M | 62.07M | 61.04M | 57.05M |
| Gross Profit | 77.43M | 234.69M | 348.57M | 253.40M | 157.14M | 202.55M | 172.98M | 165.37M | 166.68M | 128.94M | 208.09M | 200.93M | 179.64M | 174.89M | 143.25M | 145.20M | 123.61M |
| Gross Profit Ratio | 29.15% | 48.31% | 51.03% | 44.13% | 36.50% | 39.12% | 34.82% | 37.55% | 38.79% | 35.71% | 55.51% | 66.94% | 69.15% | 67.05% | 69.77% | 70.40% | 68.42% |
| Research & Development | 331.00K | 331.00K | 331.00K | 331.00K | 330.99K | 330.99K | 529.58K | 364.09K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 22.74M | 4.76M | 3.52M | 4.54M | 4.04M | 3.44M | 3.58M | 3.65M | 1.35M | 1.21M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 23.07M | 56.95M | 130.20M | 23.80M | 26.99M | 28.60M | 27.01M | 33.19M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 93.12M | 61.70M | 133.72M | 28.34M | 31.02M | 32.04M | 30.59M | 36.84M | 1.35M | 1.21M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | -3.00K | 508.00K | 508.00K | 9.63M | 15.75M | 12.40M | 4.97M | 4.33M | -1.46M | 0.00 | 0.00 | 0.00 | 563.50K | 551.95K | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 93.12M | 206.91M | 266.05M | 148.88M | 226.71M | 173.11M | 166.58M | 166.19M | 154.42M | 142.74M | 189.93M | 184.01M | 154.64M | 133.14M | 114.56M | 108.88M | 93.87M |
| Cost & Expenses | 290.66M | 458.00M | 600.60M | 469.64M | 500.08M | 488.38M | 490.35M | 441.20M | 417.45M | 374.92M | 356.74M | 283.26M | 234.77M | 219.07M | 176.63M | 169.92M | 150.93M |
| Interest Income | 5.25M | 6.17M | 5.30M | 3.40M | 1.68M | 2.80M | 2.35M | 2.13M | 1.87M | 842.25K | 2.24M | 1.49M | 929.63K | 965.89K | 669.84K | 875.69K | 681.97K |
| Interest Expense | 366.00K | 16.00K | 97.00K | 1.03M | 168.60K | 179.61K | 66.27K | 134.23K | 269.42K | 6.07M | 10.95M | 4.51M | 86.93K | 0.00 | 0.00 | 0.00 | 848.00 |
| Depreciation & Amortization | 16.87M | 17.43M | 18.13M | 15.21M | 18.30M | 18.21M | 17.92M | 18.09M | 18.04M | 18.08M | 20.73M | 21.17M | 17.50M | 8.83M | 8.33M | 8.19M | 8.27M |
| EBITDA | 4.77M | 67.92M | 119.70M | 128.64M | -38.96M | 74.56M | 32.41M | 36.26M | 32.88M | 12.07M | 25.30M | 23.07M | 41.38M | 50.40M | 54.56M | 55.23M | 167.37M |
| EBITDA Ratio | 1.80% | 12.39% | 16.83% | 22.86% | -6.80% | 13.05% | 6.52% | 5.43% | 7.56% | 1.47% | 12.44% | 14.35% | 18.69% | 24.63% | 20.48% | 21.42% | 42.90% |
| Operating Income | -17.21M | 36.09M | 68.49M | 94.57M | -85.87M | 29.46M | 3.70M | 17.21M | 14.24M | -12.62M | -7.02M | -2.61M | 23.79M | 41.57M | 46.19M | 47.24M | 159.27M |
| Operating Income Ratio | -6.48% | 7.43% | 10.03% | 16.47% | -19.95% | 5.69% | 0.74% | 3.91% | 3.31% | -3.49% | -1.87% | -0.87% | 9.16% | 15.94% | 22.50% | 22.91% | 88.16% |
| Total Other Income/Expenses | 4.75M | 13.12M | 18.06M | 7.88M | 11.13M | 25.59M | 7.08M | 19.05M | 1.00 | 1.00 | -23.28M | -20.07M | -2.00 | -213.30K | 18.28M | 11.43M | 130.39M |
| Income Before Tax | -12.46M | 49.21M | 100.58M | 112.40M | -58.44M | 55.03M | 13.48M | 17.21M | 14.24M | -12.62M | -7.01M | -2.61M | 23.79M | 41.57M | 46.23M | 47.24M | 159.27M |
| Income Before Tax Ratio | -4.69% | 10.13% | 14.72% | 19.58% | -13.57% | 10.63% | 2.71% | 3.91% | 3.31% | -3.49% | -1.87% | -0.87% | 9.16% | 15.94% | 22.52% | 22.91% | 88.16% |
| Income Tax Expense | 9.95M | 30.54M | 144.00K | -51.00K | 84.09K | 1.16M | 2.00M | 3.53M | 5.60M | 7.98M | 10.82M | 11.52M | 14.63M | 14.51M | 9.98M | 11.41M | 18.74M |
| Net Income | -22.41M | 17.56M | 100.81M | 111.29M | -58.52M | 53.87M | 11.48M | 13.68M | 8.64M | -20.60M | -12.97M | -7.13M | 15.26M | 27.06M | 36.25M | 35.83M | 140.53M |
| Net Income Ratio | -8.44% | 3.61% | 14.76% | 19.38% | -13.59% | 10.40% | 2.31% | 3.11% | 2.01% | -5.70% | -3.46% | -2.38% | 5.87% | 10.37% | 17.65% | 17.37% | 77.78% |
| EPS | -1.80 | 1.41 | 8.08 | 8.92 | -4.69 | 4.32 | 0.92 | 1.10 | 0.69 | -1.65 | -1.04 | -0.57 | 1.22 | 2.17 | 2.91 | 2.87 | 11.27 |
| EPS Diluted | -1.80 | 1.41 | 8.08 | 8.92 | -4.69 | 4.32 | 0.92 | 1.10 | 0.69 | -1.65 | -1.04 | -0.57 | 1.22 | 2.17 | 2.91 | 2.87 | 11.27 |
| Weighted Avg Shares Out | 12.45M | 12.47M | 12.47M | 12.47M | 12.47M | 12.47M | 12.47M | 12.47M | 12.47M | 12.47M | 12.47M | 12.47M | 12.47M | 12.47M | 12.47M | 12.47M | 12.47M |
| Weighted Avg Shares Out (Dil) | 12.45M | 12.47M | 12.47M | 12.47M | 12.47M | 12.47M | 12.47M | 12.47M | 12.47M | 12.47M | 12.47M | 12.47M | 12.47M | 12.47M | 12.47M | 12.47M | 12.47M |
No news found for: MEDICAPQ.BO
Source: https://incomestatements.info
Category: Stock Reports